Prostatic adenocarcinoma with urothelial (transitional cell) carcinoma features

Applied Immunohistochemistry and Molecular Morphology

Volumn 10, Issue 3, 2002, Pages 231-236

  Mai, Kien T ^a   Collins, John P ^a   Veinot, John P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Duct; Prostatic carcinoma; PSA; Urothelial cell

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; PROSTATE SPECIFIC ANTIGEN; THROMBOMODULIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; INTERMEDIATE FILAMENT PROTEIN; KERATIN; KRT20 PROTEIN, HUMAN; KRT7 PROTEIN, HUMAN; PROTEIN TYROSINE PHOSPHATASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; AUTOPSY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MIXED TUMOR; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; TRANSITIONAL CELL CARCINOMA; ADENOCARCINOMA; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, TRANSITIONAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; THROMBOMODULIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0036735361     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200209000-00008     Document Type: Article

References (23)

1. Variants of prostatic carcinoma
2. Carcinoma of prostatic ducts
3. Prostatic duct adenocarcinoma: Findings at radical prostatectomy
4. Ductal ('endometrioid') adenocarcinoma of the prostate
5. Adenocarcinoma of the prostate with endometrioid features: A light microscopic and immunohistochemical study of ten cases
6. Ductal (endometrioid) adenocarcinoma of the prostate: A clinicopathological study of 16 cases
7. Prostatic duct adenocarcinoma with endometrioid features: Immunohistochemical and electron microscopic study
8. Locally recurrent endometrioid adenocarcinoma of the prostate after radical prostatectomy
9. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinoma of various histologic differentiation
10. Papillary carcinoma of the prostate, location, morphology, and immunohistochemistry: The histogenesis and entity of so-called endometrioid carcinoma
11. Prostatic adenocarcinoma with endometrioid features: Clinical, pathologic, and ultra-structural findings
12. Surgical considerations in treatment of intraductal carcinoma of the prostate
13. Thrombomodulin expression in transitional cell carcinoma
14. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma
15. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma
16. Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy
17. The effect of androgen deprivation on malignant and benign prostate tissue
18. Histopathological effects of androgen deprivation in prostatic cancer
19. Histological and immunohistochemical findings of prostatic carcinoma after external or interstitial radiotherapy
20. Treated prostatic carcinoma: Histological, immunohistochemical and cell kinetic studies
21. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations
22. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy
23. Prostatic specific acid phosphatase immunoreactivity in adenocarcinoma